PURPOSE AND EFFECT: This rule development will consider rules necessary to implement the international prescription drug importation program as authorized by Section 499.0285, F.S., 21 U.S.C. § 384 and 21 C.F.R. Part 251.
SUBJECT AREA TO BE ADDRESSED: International Prescription Drug Importation
RULEMAKING AUTHORITY: 499.0285, FS.
LAW IMPLEMENTED: 499.01, 499.0285, FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Taya Orozco, Senior Legal Assistant, Office of the General Counsel, Division of Drugs, Devices, and Cosmetics, Department of Business and Professional Regulation; taya.orozco@myfloridalicense.com or (850)717-1177.